Security file · CUSIP 09061G101
BMRN
BIOMARIN PHARMACEUTICAL INC · US listing · held by 2 tracked managers in Q3 2026.
Tracked holders · Q3 2026
2
-1 vs Q2 2026
Aggregate reported value
$882M
sum of holders' reported positions
New holders this quarter
0
0 added · 2 trimmed
Holder return since filing
+0.8%
weighted by each holder's position share · since filing
Ownership · Q3 2026
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox Fundsfiled 13 Nov ET | 0.47% | 14.63M | -1.5% | $57 | +2.0% | $878M | Trimmed |
| 2 | Torray Fundsfiled 29 Oct ET | 0.58% | 74K | -5.3% | $59 | -0.2% | $4.42M | Trimmed |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q3 2026 | 2 | -1 | $882M | 14.70M |
| Q2 2026 | 3 | +0 | $1.29B | 22.54M |
| Q1 2026 | 3 | +1 | $1.23B | 21.70M |
| Q4 2025 | 2 | +0 | $1.22B | 20.61M |
| Q3 2025 | 2 | +0 | $1.25B | 23.01M |
| Q2 2025 | 2 | +0 | $1.51B | 27.40M |
| Q1 2025 | 2 | +0 | $1.82B | 25.76M |
| Q4 2024 | 2 | +0 | $1.66B | 25.26M |
| Q3 2024 | 2 | +1 | $1.66B | 23.65M |
| Q2 2024 | 1 | +0 | $1.15B | 13.93M |
| Q1 2024 | 1 | -1 | $1.22B | 13.99M |
| Q4 2023 | 2 | +1 | $1.39B | 14.38M |
| Q3 2023 | 1 | +0 | $1.25B | 14.15M |
| Q2 2023 | 1 | — | $1.24B | 14.29M |